產(chǎn)品概述
| 產(chǎn)品名稱（Product Name） | TNF α(Q34)Mouse Monoclonal Antibody |
| 描述（Description） | Mouse Monoclonal Antibody |
| 宿主（Host） | Mouse |
| 應用（Application） | WB,IHC-P,IF-P,IF-F,ICC/IF |
| 種屬反應性（Reactivity） | Human,Rat,Mouse |
產(chǎn)品性能
| 偶聯(lián)物（Conjugation） | Unconjugated |
| 修飾（Modification） | Unmodified |
| 同種型（Isotype） | IgG |
| 克隆（Clonality） | Monoclonal |
| 形式（Form） | Liquid |
| 存放說明（Storage） | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| 儲存溶液（Buffer） | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N. |
| 純化方式（Purification） | Affinity purification |
免疫原
| 基因名（Gene Name） | TNF TNFA TNFSF2 |
| 別名（Alternative Names） | Tumor necrosis factor (Cachectin;TNF-alpha;Tumor necrosis factor ligand superfamily member 2;TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment;NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] |
| 基因ID（Gene ID） | 7124 |
| 蛋白ID（SwissProt ID） | P01375 |
產(chǎn)品應用
| 稀釋比（Dilution Ratio） | WB 1:1000-1:3000, IHC-P 1:50-1:200, IF-P/IF-F/ICC/IF 1:50-200 |
| 蛋白分子量（Molecular Weight） | 17,25kDa |
研究背景
This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, and cancer. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Jul 2008],disease:Cachexia accompanies a variety of diseases, including cancer and infection, and is characterized by general ill health and malnutrition.,disease:Genetic variations in TNF are associated with susceptibility to hepatitis B virus infection (HBV infection) [MIM:610424]. Approximately one third of all cases of cirrhosis and half of all cases of hepatocellular carcinoma can be attributed to chronic HBV infection. HBV infection may result in subclinical or asymptomatic infection, acute self-limited hepatitis, or fulminant hepatitis requiring liver transplantation.,disease:Genetic variations in TNF are associated with susceptibility to psoriatic arthritis [MIM:607507]. Psoriasis is a chronic inflammatory dermatosis that affects approximately 2% of the population. It is characterized by red, scaly skin lesions that are usually found on the scalp, elbows, and knees, and may be associated with severe arthritis. Psoriatic arthritis has been defined as an inflammatory arthritis usually without any rheumatoid factor in serum (seronegative arthritis) associated with psoriasis.,function:Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation.,online information:The Singapore human mutation and polymorphism database,online information:Tumor necrosis factor alpha entry,PTM:O-glycosylated; glycans contain galactose, N-acetylgalactosamine and N-acetylneuraminic acid.,PTM:The membrane form, but not the soluble form, is phosphorylated on serine residues. Dephosphorylation of the membrane form occurs by binding to soluble TNFRSF1A/TNFR1.,PTM:The soluble form derives from the membrane form by proteolytic processing.,similarity:Belongs to the tumor necrosis factor family.,subunit:Homotrimer.,
研究領域
MAPK_ERK_Growth;MAPK_G_Protein;Cytokine-cytokine receptor interaction;Apoptosis_Inhibition;Apoptosis_Mitochondrial;Apoptosis_Overview;TGF-beta;Toll_Like;NOD-like receptor;RIG-I-like receptor;Hematopoietic cell lineage;Natural killer cell mediated cytotoxicity;T_Cell_Receptor;Fc epsilon RI;Adipocytokine;Type II diabetes mellitus;Type I diabetes mellitus;Alzheimer's disease;Amyotrophic lateral sclerosis (ALS);Asthma;Systemic lupus erythematosus;Allograft rejection;Graft-versus-host disease;Hypertrophic cardiomyopathy (HCM);Dilated cardiomyopathy;
關鍵字： TNF TNFA TNFSF2;TNF;α(Q34)Mouse;Monoclonal;Antibody;一抗
武漢恩璣生命科技有限公司（EnkiLife）是一家深耕生命科學，專注細胞生物學和免疫學科研試劑的研發(fā)、生產(chǎn)與銷售的生物技術企業(yè)，在全球100多個國家和地區(qū)開展業(yè)務，致力于為科研工作者提供高質(zhì)量的產(chǎn)品和卓越的客戶服務，推動生命科學的發(fā)展。
EnkiLife的產(chǎn)品線涵蓋細胞系、原代細胞、細胞培養(yǎng)基、血清、細胞檢測試劑盒、重組靶點蛋白、細胞因子、重組抗體、ELISA試劑盒、生化試劑盒等，并提供技術服務與定制開發(fā)，覆蓋了生命科學研究的各大關鍵領域，包括細胞生物學、癌癥、免疫學、神經(jīng)科學、心血管疾病、干細胞、表觀遺傳學、內(nèi)分泌、蛋白質(zhì)組學、代謝組學等，全方位滿足您的實驗需求，讓您享受科研的樂趣！
公司現(xiàn)已建立四大技術平臺：
EnCyto?細胞培養(yǎng)及檢測平臺：擁有細胞系庫（500+）、原代細胞庫（500+）、基礎培養(yǎng)基和完全培養(yǎng)基（1200+）
EnkiPro?重組蛋白平臺：現(xiàn)貨產(chǎn)品2000+，可提供定制化表達服務
EnAb?重組抗體平臺：重組兔單抗（3000+），可提供定制化和標記服務
EnKits?試劑盒開發(fā)平臺：可提供優(yōu)質(zhì)的ELISA試劑盒、配套試劑、抗體對、生化試劑盒等相關產(chǎn)品
EnkiLife在生產(chǎn)管理方面引入ISO9001質(zhì)量管理體系和信息化、自動化的管理工具，擁有高效穩(wěn)定的交付能力，與全球知名品牌建立了緊密的合作。
EnkiLife始終堅持以技術創(chuàng)新為驅動，以匠心鑄就品質(zhì)，以品質(zhì)服務客戶。
我們期待與更多的全球科研工作者和企業(yè)攜手合作，共同推動生命科學領域的進步與發(fā)展。